Figure 3. Projected Age-Standardized Oropharynx Cancer Incidence Rates per 100 000 Population by Sex in Individuals 36 to 45 Years of Age and 46-55 Years of Age Under Current Human Papillomavirus (HPV) Vaccination Rates Compared With the Scenario of Expected Incidence With No Vaccination for 2018 to 2045.

Solid lines represent the projected age-standardized oropharynx cancer incidence rates in the scenario of no vaccination. Dashed lines represent the projected age-standardized oropharynx incidence rates under current HPV vaccination rates. Shaded areas represent 95% CIs for the estimates of oropharynx cancer incidence rates.